Prevention and treatment of hemodialysis-related bloodstream infections.

abstract：:Dialysis vascular access associated coronary-subclavian steal or hypoperfusion syndrome is an uncommon but potentially life threatening condition. Awareness of this syndrome is important in the management of vascular access in hemodialysis patients. We report a case of dialysis vascular access associated coronary-subc...

journal_title：Seminars in dialysis

authors： Tan CS,Fintelmann F,Joe J,Ganguli S,Wu S

更新日期：2013-09-01 00:00:00

abstract：:There has been substantial growth in the variety of available antidiabetic agents during the last decade and a half. The role of these newer agents in patients with diabetes and end-stage renal disease (ESRD) population, and their relative benefits and risks in this population compared to patients without ESRD are not...

journal_title：Seminars in dialysis

authors： Boyle SM,Simon B,Kobrin SM

更新日期：2015-07-01 00:00:00

abstract：:Data derived from a large cohort of hemodialysis patients (12,896) undergoing dialysis access maintenance procedures being performed by interventional nephrologists were analyzed to determine the safety of sedation/analgesia (S/A) in a freestanding facility. Data collected included patient demographics, procedures per...

journal_title：Seminars in dialysis

authors： Beathard GA,Urbanes A,Litchfield T,Weinstein A

更新日期：2011-01-01 00:00:00

abstract：:Dialysis providers are increasingly being presented with progressively older and frailer patients, in all healthcare settings from the acute hospital to the community dialysis center. These patients commonly bring more than kidney failure with them, with a complex constellation of chronic illness, comorbidity, and fun...

journal_title：Seminars in dialysis

authors： Wiggins J,Bitzer M

更新日期：2012-11-01 00:00:00

abstract：:It has been clearly established that critically ill patients with sepsis require prompt fluid resuscitation. The optimal amount of fluid and when to taper this resuscitation is less clear. There is a growing evidence that fluid overload leads to acute kidney injury, and increased morbidity and mortality. A clinician's...

journal_title：Seminars in dialysis

authors： Colbert GB,Szerlip HM

更新日期：2019-01-01 00:00:00

abstract：:In performing percutaneous renal biopsy (PRB) of native kidneys, an increasing use of 16-gauge automated biopsy needles has been observed. We compare the adequacy and safety of PRBs in adults performed with a 14-gauge (n = 82) vs. 16-gauge (n = 55) automated needle using real-time ultrasound (US) from 1/2010 to 12/201...

journal_title：Seminars in dialysis

authors： Chunduri S,Whittier WL,Korbet SM

更新日期：2015-03-01 00:00:00

abstract：:Peritoneal dialysis (PD) is a markedly underutilized modality for permanent renal replacement therapy in the United States owing to a low rate of patient referral and high rate of patient dropout or transfer to hemodialysis. One cause for patient loss from PD is problematic PD catheters that often are removed rather t...

journal_title：Seminars in dialysis

authors： Asif A,Gadalean F,Vieira CF,Hogan R,Leon C,Merrill D,Ellis R,Amador A,Broche O,Bush B,Contreras G,Pennell P

更新日期：2006-03-01 00:00:00

abstract：:Hypermagnesemia is an uncommon electrolyte abnormality, due to the fact that magnesium toxicity is only seen in the setting of a massive exposure to exogenous magnesium, often in the setting of renal insufficiency. Here, we report a case of severe hypermagnesemia that resulted in complete paralysis that was secondary ...

journal_title：Seminars in dialysis

authors： Bansal AD,Negoianu D,Warburton KM

更新日期：2016-05-01 00:00:00

abstract：:Over the past decade, patients returning to dialysis after a failed transplant comprised of 5-10% of the annual number of dialysis initiations in the United States, whereas retransplant candidates account for 5.0-13% of the annual deceased donor wait-list additions. The United States Renal Data System (USRDS) database...

journal_title：Seminars in dialysis

authors： Pham PT,Pham PC

更新日期：2011-05-01 00:00:00

abstract：:Patients undergoing chronic renal replacement therapy have a high incidence of dyslipidemia. In general, there are increased concentrations of triglyceride-rich apolipoprotein B-containing particles. These elevations lead to increased levels of non-high-density lipoprotein (HDL) levels. This pattern is further modifie...

journal_title：Seminars in dialysis

authors： Liu J,Rosner MH

更新日期：2006-01-01 00:00:00

abstract：:Traction and cutdown techniques can successfully remove a tunneled dialysis catheter (TDC) in a great majority of patients. However, these methods may not be successful in patients with catheters that are tethered or attached to the central veins or the atrium. A forceful application of traction can lead to catheter b...

journal_title：Seminars in dialysis

authors： Carrillo RG,Garisto JD,Salman L,Merrill D,Asif A

更新日期：2009-11-01 00:00:00

abstract：:Hyperphosphatemia is an independent risk factor for mortality in patients on maintenance dialysis. Since phosphorus clearance by standard three times-weekly dialysis is insufficient to balance ongoing dietary phosphorus intake, strategies to prevent absorption of dietary phosphorus are essential for attenuating increa...

journal_title：Seminars in dialysis

authors： Gutiérrez OM,Wolf M

更新日期：2010-07-01 00:00:00

abstract：:The treatment of end-stage renal disease (ESRD) makes extensive use of presterilized disposable items which, after use, are contaminated by blood. The preferred route of disposal of such items is by incineration. Disposal costs have risen and this increase in costs has not been matched by waste management programs in ...

journal_title：Seminars in dialysis

authors： Hoenich NA,Levin R,Pearce C

更新日期：2005-09-01 00:00:00

abstract：:Depression has been documented as the most frequently encountered psychological problem in end-stage renal disease (ESRD) patients and has been correlated with both mortality and morbidity in these patients. Previous work by our group has shown that clinical depression is treatable with psychotropic medications in the...

journal_title：Seminars in dialysis

authors： Wuerth D,Finkelstein SH,Kliger AS,Finkelstein FO

更新日期：2003-11-01 00:00:00

abstract：:Anabolic steroids have been used for the treatment of the anemia of chronic renal failure for more than 25 years. Due to concerns over adverse effects, their use historically has been limited to nandrolone decanoate given to men, usually over age 50, who have intact kidneys. The introduction of epoetin alfa in 1989 ha...

journal_title：Seminars in dialysis

authors： Johnson CA

更新日期：2000-01-01 00:00:00

abstract：:Intradialytic hypotension (IDH) is a common complication of hemodialysis and is associated with numerous adverse outcomes including cardiovascular events, inadequate dialysis, loss of vascular access, and death. It is estimated that approximately 20%-30% of all dialysis sessions are affected by IDH. In seeking ways to...

journal_title：Seminars in dialysis

authors： Chang TI

更新日期：2017-11-01 00:00:00

abstract：:Dialysis remains the predominant form of renal replacement therapy in the United States, but the optimal timing for the initiation of dialysis remains poorly defined. Not only clinical factors such as signs/symptoms of uremia, co-existing cardiovascular disease, and presence of diabetes but also key demographic charac...

journal_title：Seminars in dialysis

authors： Streja E,Nicholas SB,Norris KC

更新日期：2013-11-01 00:00:00

abstract：:Chronic unexplained inflammation remains a prevalent and clinically significant problem for patients with end-stage kidney disease (ESKD), especially in the dialysis population. The causes of persistent inflammation are likely to be multifactorial, but the underlying mechanisms remain to be elucidated. Endotoxins are ...

journal_title：Seminars in dialysis

authors： Wong J,Vilar E,Farrington K

更新日期：2015-01-01 00:00:00

abstract：:Antibiotic prophylaxis has been employed to reduce the risk of infection. Many reports have documented the role of prophylactic antibiotics on the subsequent development of infection in patients undergoing surgical as well as a variety of percutaneous interventions including cardiac, vascular, biliary, genitourinary, ...

journal_title：Seminars in dialysis

authors： Salman L,Asif A

更新日期：2009-05-01 00:00:00

abstract：:Extracorporeal elimination of drugs and toxins is a critical component in the management of poisonings, though specific techniques and indications remain a matter of debate. Conventional hemodialysis is frequently the treatment of choice because of its widespread availability and proven effectiveness for certain drugs...

journal_title：Seminars in dialysis

authors： Goodman JW,Goldfarb DS

更新日期：2006-09-01 00:00:00

abstract：:Hypertension among patients on hemodialysis is common, difficult to diagnose and often inadequately controlled. Although specific blood pressure (BP) targets in this particular population are not yet established, meta-analyses of randomized trials showed that deliberate BP-lowering with antihypertensive drugs improves...

journal_title：Seminars in dialysis

authors： Georgianos PI,Agarwal R

更新日期：2018-11-01 00:00:00

abstract：:The patency of the vascular access (VA) is a fight for the attending nephrologist. A retrospective observational study was conducted to compare the success rate of surgical versus endovascular technique percutaneous transluminal angioplasty (PTA) for graft thrombosis treatment. Of 3008 patients, 22.1% patients were di...

journal_title：Seminars in dialysis

authors： Ponce P,Carvalho T,Messias H,Neves F,Lisbon VAC Interventional Nephrology Team.

更新日期：2014-09-01 00:00:00

abstract：:Pulmonary hypertension (PH) is a progressive, fatal pulmonary circulatory disease that accompanies many conditions (including left to right side shunt) with compensatory elevated cardiac output. PH also complicates chronic hemodialysis (HD) therapy immediately after the creation of an arteriovenous (AV) access, even b...

journal_title：Seminars in dialysis

authors： Yigla M,Abassi Z,Reisner SA,Nakhoul F

更新日期：2006-09-01 00:00:00

abstract：:Late referral of patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) for evaluation of kidney transplantation is common. Even though renal transplantation offers a clear survival benefit to patients with advanced CKD and ESRD and should be considered the renal replacement therapy of choice, n...

journal_title：Seminars in dialysis

authors： Peev V

更新日期：2016-07-01 00:00:00

abstract：:Translumbar tunneled dialysis catheter (TLDC) is a temporary dialysis access for patients exhausted traditional access for dialysis. While few small studies reported successes with TLDC, additional studies are warranted to understand the short- and long-term patency and safety of TLDC. We conducted a retrospective ana...

journal_title：Seminars in dialysis

authors： Liu F,Bennett S,Arrigain S,Schold J,Heyka R,McLennan G,Navaneethan SD

更新日期：2015-07-01 00:00:00

abstract：:The use of stents has been steadily increasing in the management of dialysis access dysfunction. The purpose of this report was to review the use of covered stents in failed forearm fistulas and describe a case of the use of a small caliber forearm covered stent in a early failed forearm fistula that allowed dialysis ...

journal_title：Seminars in dialysis

authors： Ross JL

更新日期：2009-01-01 00:00:00

abstract：:In this article we deal with three aspects of acidosis in patients with chronic renal insufficiency: clinical characteristics, pathophysiology, and therapeutic approach. ...

journal_title：Seminars in dialysis

authors： Uribarri J

更新日期：2000-07-01 00:00:00

abstract：:Until the discovery of calcimimetics, the management of secondary hyperparathyroidism (SHPT) relied exclusively on treatment with phosphate binders, vitamin D derivatives or surgical parathyroidectomy with limited success. The therapeutic use of calcimimetic agents, together with a better understanding of the pivotal ...

journal_title：Seminars in dialysis

authors： Rodríguez M,Goodman WG,Liakopoulos V,Messa P,Wiecek A,Cunningham J

更新日期：2015-09-01 00:00:00

abstract：:Congestive heart failure (CHF) is highly prevalent in patients on renal replacement therapy and is a leading cause of death in such patients. Several studies suggest that therapeutic agents for the treatment of CHF, particularly angiotensin converting enzyme inhibitors and beta-blockers, are underused in end-stage ren...

journal_title：Seminars in dialysis

authors： Bouchard J,Madore F

更新日期：2007-09-01 00:00:00

abstract：:This publication comments on the recently published findings of a study by Eloot et al. (cJASN, 6: 1266-1273, 2011) that evaluated the correlation between several formulae for calculating estimated GFR (eGFR) and different low molecular weight uremic toxins; eGFRs were based on serum creatinine (SCrea), cystatin C (Cy...

journal_title：Seminars in dialysis

authors： Vanholder R,Eloot S,Schepers E,Neirynck N,Glorieux G,Massy Z

更新日期：2012-01-01 00:00:00